05 August 2022
This month was another great month for our biotech companies. BioTechNZ ran a very successful workshop in Wellington last week - Accelerating Crop Bioprotectant Development from New Zealand - with 50+ people in attendance. As well, the BioTechNZ Executive Council has been out and about talking to Government ministers about the role of biotech in New Zealand (traditional to modern biotech).
Read More
06 July 2022
After more than two years of making connections via Zoom, members are eager to reconnect face-to-face and move around New Zealand and internationally. The border opening will greatly accelerate the change.
Read More
21 June 2022
It will surprise nobody that for the 12th year in a row, world-class biosecurity has taken the overall #1 spot in the annual KPMG agribusiness industry leader’s priority survey, BiotechNZ executive director Dr Zahra Champion says. The Ministry for Primary Industries suggest total exports of food and fibre products for the year to the end … Continue reading "All about the woman fighting for gender equality, one female CEO at a time"
Read More
Biotechnology consultant Topaz Conway, here as part of the Vogue Codes series, writes about how women can make their mark in the entrepreneurial world. Tales of paths travelled always deliver enduring anticipation, where the expectation is for triumph to reign and the pioneers to reap the benefit
July 31, 2017
Agriculture has come a long way in the past century. We produce more food than ever before -- but our current model is unsustainable, and as the world’s population rapidly approaches the 8 billion mark, modern food production methods will need a radical transformation if they're going to keep up.
July 30, 2017
Viome, the wellness monitoring service founded by Seattle-area tech entrepreneur Naveen Jain, has raised $15 million this month in an investment round, according to documents filed today with the Securities and Exchange Commission. The equity sale boosts the first commercial venture brought to li
July 28, 2017
Family movie night can be fraught in biotech households. Earlier this month, John Crowley, CEO of Amicus Therapeutics, cued up “Rise of the Planet of the Apes” as a refresher before the debut of its blockbuster sequel. Soon his living room played host to a man with roughly his job, working at
July 26, 2017